Table 3.
Hormonal disorders and self-report questionnaire percentiles for individual participants who screened positive for hypopituitarism.
Identifiers | Deficiency | PCL-M | NSI | PHQ-9 | PSQI | AUDIT-C |
---|---|---|---|---|---|---|
Mild traumatic brain injuries (mTBI)-A | GHD | 98 | 92 | 98 | 90 | 22 |
mTBI-B | GHD | 82 | 88 | 83 | 97 | 85 |
mTBI-C | Diabetes insipidus (DI) | 55 | 56 | 38 | 97 | 5 |
mTBI-D | Hypothyroidism, DI | 94 | 97 | 98 | 57 | 85 |
mTBI-E | GHD, hypogonadism, hyperprolactinemia | 78 | 69 | 72 | NS | 38 |
mTBI-F | Hypothyroidism | 98 | 99 | 98 | 35 | 11 |
mTBI-G | Hypogonadism | 98 | 99 | 97 | 87 | 99 |
mTBI-H | Hypooxytocinemia | 74 | 60 | 53 | 29 | 56 |
mTBI-I | GHD | 49 | 39 | 29 | 23 | 11 |
mTBI-J | GHD | 18 | 45 | 25 | 23 | 72 |
mTBI-K | DI | 51 | 35 | 21 | 87 | 93 |
mTBI-L | GHD, hypooxytocinemia | 22 | 22 | 14 | 23 | 97 |
DC-A | GHD | 57 | 37 | 58 | 57 | 56 |
DC-B | GHD | 10 | 12 | 14 | 5 | 56 |
DC-C | Hyperprolactinemia | 53 | 41 | 58 | 64 | 11 |
Percentile is based on the ranking of all participants. The higher the percentile, the more severe or frequent the symptoms endorsed. The participant identifiers in the far-left column are “dummy” identifiers and are not the participant identification sequences used in the study. Percentile values falling in the highest (fourth) quartile of scores are highlighted in yellow.
GHD, growth hormone deficiency; PCL-M, Posttraumatic Stress Disorder CheckList-Military; NSI, Neurobehavioral Symptom Inventory; PHQ-9, Patient Health Questionnaire-9; PSQI, Pittsburgh Sleep Quality Index; AUDIT-C, Alcohol Use Disorders Identification Test-Consumption; NS, no score.